Jan 9 (Reuters) - Moderna Inc is considering
pricing its COVID-19 shot at $110 to $130 per dose in the United
States when it shifts from government contracting to commercial
distribution of the shots, the company's Chief Executive Officer
Stephane Bancel told the Wall Street Journal on Monday.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Krishna
Chandra Eluri)